Texas Heart Institute journal最新文献_第4页

Evidence and Practicality of Real-Time Ultrasound-Guided Procedures in the Intensive Care Unit: A New Skill Set for the Intensivist. 重症监护病房实时超声引导程序的证据和实用性:重症监护医师的新技能。

IF 0.9 4区医学

Texas Heart Institute journal Pub Date : 2023-07-01 DOI: 10.14503/THIJ-23-8166

Jacqueline Sohn, Min Se Cha

引用次数: 0

End-of-Life Issues in Patients With Left Ventricular Assist Devices. 使用左心室辅助装置患者的临终问题。

IF 0.9 4区医学

Texas Heart Institute journal Pub Date : 2023-07-01 DOI: 10.14503/THIJ-23-8160

Mary Acelle G Garcia, Astrid Grouls

引用次数: 0

Pearls in Anticoagulation Management for Patients With Left Ventricular Assist Devices. 珍珠在左心室辅助装置患者抗凝管理中的应用。

IF 0.9 4区医学

Texas Heart Institute journal Pub Date : 2023-07-01 DOI: 10.14503/THIJ-23-8154

Ellen Yin

引用次数: 0

Trigeminal Amyloidoma in a Patient With Cardiac Amyloidosis. 心脏淀粉样变性患者的三叉淀粉样瘤。

IF 0.9 4区医学

Texas Heart Institute journal Pub Date : 2023-07-01 DOI: 10.14503/THIJ-22-8071

Nikita Jhawar, Razvan Chirila, Juan Carlos Leoni Moreno

引用次数: 0

Early Intraoperative Detection and Management of Right Ventricular Failure After Left Ventricular Assist Device Implantation. 左心室辅助装置植入后右室衰竭的早期术中检测与处理。

IF 0.9 4区医学

Texas Heart Institute journal Pub Date : 2023-07-01 DOI: 10.14503/THIJ-23-8169

Thomas R Powell

引用次数: 0

Management of Cardiogenic Shock: Present and Future. 心源性休克的处理:现在和未来。

IF 0.9 4区医学

Texas Heart Institute journal Pub Date : 2023-05-01 DOI: 10.14503/THIJ-23-8119

Nikolaos A Diakos

引用次数: 0

Atrioventricular Nodal Ablation Is Not an Effective Treatment Strategy in Catecholaminergic Polymorphic Ventricular Tachycardia. 房室结消融不是儿茶酚胺能多形性室性心动过速的有效治疗策略。

IF 0.9 4区医学

Texas Heart Institute journal Pub Date : 2023-05-01 DOI: 10.14503/THIJ-22-7974

S Yukiko Asaki, David Kessler, Aarushi Nayak, Jeffrey J Kim, Christina Y Miyake

{"title":"Atrioventricular Nodal Ablation Is Not an Effective Treatment Strategy in Catecholaminergic Polymorphic Ventricular Tachycardia.","authors":"S Yukiko Asaki, David Kessler, Aarushi Nayak, Jeffrey J Kim, Christina Y Miyake","doi":"10.14503/THIJ-22-7974","DOIUrl":"https://doi.org/10.14503/THIJ-22-7974","url":null,"abstract":"Catecholaminergic polymorphic ventricular tachycardia is a rare but lethal heritable arrhythmia syndrome associated with both atrial and ventricular arrhythmias. Treatment includes antiarrhythmics, sympathetic denervation, and implantable cardioverter-defibrillators. The use of atrioventricular nodal ablation as a treatment strategy to prevent ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia was not found in the literature. This report describes a teenager with a presenting rhythm of atrial and ventricular fibrillation and cardiac arrest. Her clinical arrhythmia was predominantly atrial dysrhythmias, which delayed her diagnosis of catecholaminergic polymorphic ventricular tachycardia. Before her diagnosis, she underwent atrioventricular nodal ablation in an effort to prevent ventricular arrhythmias, which was ultimately ineffective. This report highlights the importance of recognizing atrial arrhythmias in catecholaminergic polymorphic ventricular tachycardia and provides evidence that atrioventricular nodal ablation is not an effective treatment strategy for this disease.","PeriodicalId":22352,"journal":{"name":"Texas Heart Institute journal","volume":"50 3","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353275/pdf/i1526-6702-50-3-e227974.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9834841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Postpartum Detection of Diastolic Dysfunction and Nondipping Blood Pressure Profile in Women With Preeclampsia. 子痫前期妇女舒张功能不全和非浸入性血压的产后检测。

IF 0.9 4区医学

Texas Heart Institute journal Pub Date : 2023-05-01 DOI: 10.14503/THIJ-20-7459

Marwa Sayed, Mariam Rashed, Ahmed M Abbas, Amr Youssef, Mohamed Abdel Ghany

{"title":"Postpartum Detection of Diastolic Dysfunction and Nondipping Blood Pressure Profile in Women With Preeclampsia.","authors":"Marwa Sayed, Mariam Rashed, Ahmed M Abbas, Amr Youssef, Mohamed Abdel Ghany","doi":"10.14503/THIJ-20-7459","DOIUrl":"https://doi.org/10.14503/THIJ-20-7459","url":null,"abstract":"Background: Left ventricular diastolic dysfunction and nocturnal \"nondipping\" of blood pressure detected via ambulatory blood pressure monitoring are predictors of increased cardiovascular morbidity.Methods: A prospective cohort study including normotensive women with a history of preeclampsia in their current pregnancy was conducted. All cases were subjected to 24-hour ambulatory blood pressure monitoring and 2-dimensional transthoracic echocardiography 3 months after delivery.Results: This study included 128 women with a mean (SD) age of 28.6 (5.1) years and a mean (SD) basal blood pressure of 123.1 (6.4)/74.6 (5.9) mm Hg. Among the participants, 90 (70.3%) exhibited an ambulatory blood pressure monitoring profile illustrating nocturnal blood pressure \"dipping\" (the mean night to day time blood pressure ratio ≤ 0.9), whereas 38 (29.7%) were nondippers. Diastolic dysfunction (impaired left ventricular relaxation) was present in 28 nondippers (73.7%), whereas none of the dippers exhibited diastolic dysfunction. Women with severe preeclampsia were more frequently nondippers (35.5% vs 24.2%; P = .02) and experienced diastolic dysfunction (29% vs 15%; P = .01) than were those with mild preeclampsia. Severe preeclampsia (odds ratio [OR], 1.08; 95% CI, 1.05-10.56; P < .001) and history of recurrent preeclampsia (OR, 1.36; 95% CI, 1.3-4.26; P ≤ .001) were significant predictors for nondipping status and diastolic dysfunction (OR, 1.55; 95% CI, 1.1-2.2; and OR, 1.23; 95% CI, 1.2-2.2, respectively; P < .05).Conclusion: Women with a history of preeclampsia were at higher risk for developing late cardiovascular events. The severity and recurrence of preeclampsia were significant predictors of both nondipping profile and diastolic dysfunction.","PeriodicalId":22352,"journal":{"name":"Texas Heart Institute journal","volume":"50 3","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353267/pdf/i1526-6702-50-3-e207459.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10192693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

In Memoriam: Michael R. Nihill, MBBS (1936-2023). 纪念:Michael R. Nihill, MBBS(1936-2023)。

IF 0.9 4区医学

Texas Heart Institute journal Pub Date : 2023-05-01 DOI: 10.14503/THIJ-23-8151

Wayne J Franklin, Colin J McMahon, Daniel J Penny

引用次数: 0

P2Y12 Inhibitors for Non-ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis. P2Y12抑制剂治疗非st段抬高急性冠脉综合征：系统回顾和网络荟萃分析

IF 0.8 4区医学

Texas Heart Institute journal Pub Date : 2023-05-01 DOI: 10.14503/THIJ-22-7916

Tomohiro Fujisaki, Toshiki Kuno, Alexandros Briasoulis, Naoki Misumida, Hisato Takagi, Azeem Latib

{"title":"P2Y12 Inhibitors for Non-ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis.","authors":"Tomohiro Fujisaki, Toshiki Kuno, Alexandros Briasoulis, Naoki Misumida, Hisato Takagi, Azeem Latib","doi":"10.14503/THIJ-22-7916","DOIUrl":"10.14503/THIJ-22-7916","url":null,"abstract":"Background: For patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS), prasugrel was recommended over ticagrelor in a recent randomized controlled trial, although more data are needed on the rationale. Here, the effects of P2Y12 inhibitors on ischemic and bleeding events in patients with NSTE-ACS were investigated.Methods: Clinical trials that enrolled patients with NSTE-ACS were included, relevant data were extracted, and a network meta-analysis was performed.Results: This study included 37,268 patients with NSTE-ACS from 11 studies. There was no significant difference between prasugrel and ticagrelor for any end point, although prasugrel had a higher likelihood of event reduction than ticagrelor for all end points except cardiovascular death. Compared with clopidogrel, prasugrel was associated with decreased risks of major adverse cardiovascular events (MACE) (hazard ratio [HR], 0.84; 95% CI, 0.71-0.99) and myocardial infarction (HR, 0.82; 95% CI, 0.68-0.99) but not an increased risk of major bleeding (HR, 1.30; 95% CI, 0.97-1.74). Similarly, compared with clopidogrel, ticagrelor was associated with a reduced risk of cardiovascular death (HR, 0.79; 95% CI, 0.66-0.94) and an increased risk of major bleeding (HR, 1.33; 95% CI, 1.00-1.77; P = .049). For the primary efficacy end point (MACE), prasugrel showed the highest likelihood of event reduction (P = .97) and was superior to ticagrelor (P = .29) and clopidogrel (P = .24).Conclusion: Prasugrel and ticagrelor had comparable risks for every end point, although prasugrel had the highest probability of being the best treatment for reducing the primary efficacy end point. This study highlights the need for further studies to investigate optimal P2Y12 inhibitor selection in patients with NSTE-ACS.","PeriodicalId":22352,"journal":{"name":"Texas Heart Institute journal","volume":"50 3","pages":""},"PeriodicalIF":0.8,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353270/pdf/i1526-6702-50-3-e227916.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9837624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0